Fondazione Edmund Mach Report issue

Foundation

Organization Overview

First Clinical Trial
2014
NCT02067026
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Fondazione Edmund Mach

Active Ingredients

Drugs in Other Trials (5)

abo-glyc (1 trial)

aleurone (1 trial)

apple (1 trial)

lactobacillus reuteri (1 trial)

oat (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 5